Dr. Druker is a prototypal example of a physician scientist and all that can be achieved in a career in medicine and science. Don’t miss this opportunity to hear the story of imatinib from Dr. Druker himself as well as hear his advice for success as a physician scientist!
APSA is excited to announce our spring 2017 keynote interactive session with Dr. Brian Druker, an icon in oncology and precision medicine. Dr. Druker’s research led to the development of imatinib, the first clinically approved drug specifically targeted the molecular defect of a cancer. Imatinib transformed CML from a devastating and fatal cancer to a disease that can be held in long-term remission with a well-tolerated oral medication.
Please join us on March 22, 2017 at 5:00pm EDT. Call in information is below:
Interactive Session with Dr. Brian Druker
Wed, Mar 22, 2017 5:00 PM - 6:00 PM EDT
Please join my meeting from your computer, tablet or smartphone.
You can also dial in using your phone.
United States: +1 (872) 240-3412
Access Code: 182-533-197
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.